Learn more about do anti-inflammatory drugs undermine the use of MRI as a means of assessing inflammation in axial spondyloarthritis?
Learn about our research into whether the RUNX3 gene, which is important for immune cells, can be targeted for the development of new and effective treatments.
Learn about our research into access to treatments, such as physical activity and talking therapy, to alleviate fatigue from inflammatory rheumatic conditions.
Read more about our research into messengers in the immune system (GM-CSF), their role in causing ankylosing spondylitis and whether they can be targeted.
Learn more about our research into gut bacteria and their role in the development of inflammatory arthritis and in determining your response to treatment.
Read about our research into understanding how T cells are involved in causing disease and identifying potential new treatments to target the T-cells.
Read about our research, which aims to build upon evidence that the NOS2 gene plays a role in ankylosing spondylitis to help to develop new treatments.
Read how our research group have pioneered the use of zebrafish, which have similar genes to humans, for research into osteoarthritis and related conditions.
Learn more about if a new blood thinning drug improve treatment for patients with lupus or thrombotic antiphospholipid syndrome at risk of stroke.
Learn about our research and study of two genes - aiming to improve our understanding of the processes involved in controlling inflammation and bone damage.
Read about our research on how replacing gut bacteria could treat people with axial spondyloarthritis.